African Americans’ Perception of Risk for Diabetes Complications

The Diabetes Educator

Volumn 37, Issue 5, 2011, Pages 689-698

  Calvin, Donna ^a,b   Quinn, Lauretta ^a   Dancy, Barbara ^a   Park, Chang ^a   Fleming, Shirley G ^c   Smith, Eva ^a   Fogelfeld, Leon ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Jr Hospital of Cook County   (United States)

^c CHICAGO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADAPTIVE BEHAVIOR; ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ALBUMINURIA; ARTICLE; ATTITUDE TO HEALTH; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ETHNOLOGY; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POVERTY; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; UNITED STATES;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; ALBUMINURIA; CHICAGO; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POVERTY AREAS; RISK ASSESSMENT;

EID: 80052815134     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721711416258     Document Type: Article

References (56)

1. American Diabetes Association. Diabetes statistics. http://www.diabetes.org/diabetes-statistics.jsp. Accessed February 23, 2010.
2. American Diabetes Association. African American and diabetes facts. http://www.diabetes.org/communityprograms-and-localevents/africanamerican/facts.jsp. Accessed February 23, 2010.
3. Carter JS, Pugh JA, Monterrosa A. Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med. 1996;125(3):221.
4. United States Renal Data System. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2009.
5. Norris KC, Agodoa LY. Unraveling the racial disparity associated with kidney disease. Kidney Int. 2005;68:914-924.
6. Goldschmid MG, Domin WS, Ziemer DC, Gallina DL, Phillips LS. Diabetes in urban African Americans: II. High prevalence of microalbuminuria and nephropathy in African Americans with diabetes. Diabetes Care. 1995;18(7):955-961.
7. Young BA, Katon WJ, Von Korff M et al. Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study. J Am Soc Nephrol. 2005;16(1):219-228.
8. Reikes S. Trends in end stage renal disease. J Postgrad Med. 2000;108(1):124-142.
9. Lewis E, Hunsicker L, Bain R, Rohde R; for the Collaborative Study Group. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329(20):1456-1462.
10. Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C, Weir D. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med. 2007;167(17):1853.
11. Kirk JK, Bell RA, Bertoni AG et al. Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes. Ann Pharmacother. 2005;39(9):1489-1501.
12. Kirk JK, D'Agostino RB Jr, Bell RA et al. Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes. Diabetes Care. 2006;29(9):2130-2136.
13. Centers for Disease Control and Prevention. National Center for Health Statistics Health, United States, 2007 With Chartbook on Trends in the Health of Americans. Hyattsville, Maryland: US Department of Health and Human Services; 2007.
14. Agoda L. Lessons from chronic renal disease in African Americans: treatment implications. Ethn Dis. 2003;13(suppl 2):118-124.
15. Williams DR, Lavizzo-Mourey R, Warren RC. The concept of race and health status in the United States. Public Health Rep. 1994;109(1):26-41.
16. Egede L, Dagogo-Jack S. Epidemiology of type 2 diabetes: focus on ethnic minorities. Med Clin North Am. 2005;89(5):949-975.
17. Williams DR. Socioeconomic differentials in health: a review and redirection. Soc Psychol Q. 1990;53(2):81-99.
18. Tarver-Carr ME, Powe NR, Eberhardt MS et al. Excess risk of chronic kidney disease among African American versus White subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol. 2002;13(9):2363-2370.
19. Leventhal H, Diefenbach M, Leventhal E. Illness cognition: using commonsense to understand treatment adherence and affect cognition interactions. Cognit Ther Res. 1992;16(2):143-163.
20. Harrison TA, Hindorff LA, Kim H et al. Family history of diabetes as a potential public health tool. Am J Prev Med. 2003;24(2):152-159.
21. Leventhal H, Nerenz D, Steele D. Illness representation and coping with health threats. In: Baum T, ed. Handbook of Psychology and Health. Hillsdale, NJ: Lawrence Erlbaum; 1984:219-253.
22. Leventhal H, Brissette I, Leventhal EA. The common-sense model of self-regulation of health and illness. In: Cameron L, Leventhal H, eds. The Self-Regulation of Health and Illness Behaviour. London, UK: Routledge; 2003:42-65.
23. Murphy E, Kinmonth AL. No symptoms, no problem? Patients’ understandings of non-insulin dependent diabetes. Fam Pract. 1995;12(2):184-192.
24. Stover JC, Skelly AH, Holditch-Davis D, Dunn PF. Perceptions of health and their relationship to symptoms in African American women with type 2 diabetes. Appl Nurs Res. 2001;14(2):72-80.
25. Cameron L, Leventhal EA, Leventhal H. Symptom representations and affect as determinants of care seeking in a community-dwelling, adult sample population. Health Psychol. 1993;12:171-179.
26. Walker E, Caban A, Schechter C et al. Measuring comparative risk perceptions in an urban minority population: the risk perception survey for diabetes. Diabetes Educ. 2007;33(1):103-110.
27. Van der Plight J. Perceived risk and vulnerability as predictors of precautionary behaviour. Br J Health Psychol. 1998;3:1-14.
28. Paschalides C, Wearden A, Dunkerley R, Bundy C, Davies R, Dickens C. The associations of anxiety, depression and personal illness representations with glycaemic control and health-related quality of life in patients with type 2 diabetes mellitus. J Psychosom Res. 2004;57(6):557-564.
29. Edgar KA, Skinner TC. Illness representations and coping as predictors of emotional well-being in adolescents with type 1 diabetes. J Pediatr Psychol. 2003;28(7):485-493.
30. Law GU, Kelly TP, Huey D, Summerbell C. Self-management and well-being in adolescents with diabetes mellitus: do illness representations play a regulatory role. J Adolesc Health. 2002;31(4):381-385.
31. Bradley C. The 12 item well being questionnaire. Diabetes Care. 2000;23(6):875.
32. Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D. The Revised Illness Perception Questionnaire (IPQ-R). Psychol Health. 2002;17(1):1-16.
33. Walker EA, Schechter CB, Caban A, Basch CE. Telephone intervention to promote diabetic retinopathy screening among the urban poor. Am J Prev Med. 2008;34(3):185.
34. Bradley C. The Well-Being Questionnaire. In: Bradley C, ed. Handbook of Psychology and Diabetes. Berkshire, UK: Psychology Press; 1994:89-107.
35. Mitchell J, Bradley C. Psychometric evaluation of the 12 item well-being questionnaire for use with people with macular disease. Qual Life Res. 2001;10(5):465-473.
36. John W, Edwards R, Price C. Laboratory evaluation of the DCA 2000 clinic HbA1c immunoassay analyser. Ann Clin Biochem. 1994;31(pt 4):367-370.
37. Carter JS, Houston CA, Gilliland SS et al. Rapid HbA1c testing in a community setting. Diabetes Care. 1996;19(7):764-767.
38. Parsons MP, Newman DJ, Newall RG, Price CP. Validation of a point-of-care assay for the urinary albumin:creatinine ratio. Clin Chem. 1999;45(3):414-416.
39. National Heart, Blood, and Lung Institute. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf. Accessed August 5, 2010.
40. Carp F. Maximizing data quality in community studies of older people. In: Lawton MP, Herzog AR, eds. Special Research Methods for Gerontology. Amityville, NY: Baywood Publishing Co; 1989:93-122.
41. Johnson T, O'Rourke D, Chavez N et al. Social cognition and responses to survey questions among culturally diverse populations. In: Lyberg L, Biemer P, Collins M et al., eds. Survey Measurement and Process Quality. New York, NY: John Wiley & Sons; 1997:87-113.
42. Frijling BD, Lobo CM, Keus IM et al. Perceptions of cardiovascular risk among patients with hypertension or diabetes. Patient Educ Couns. 2004;52(1):47-53.
43. Karlsen B, Bru E, Hanestad R. Self reported psychological well-being and disease related strains among adults with diabetes. Psychol Health. 2002;17(4):459-473.
44. Johnson L, Staples R. Kinship and community support. In: Black Families at the Crossroads; Challenges and Prospects. 2nd ed. San Francisco, CA: Jossey-Bass; 2005:245-276.
45. Fitzgerald JT, Gruppen LD, Anderson RM et al. The influence of treatment modality and ethnicity on attitudes in type 2 diabetes. Diabetes Care. 2000;23(3):313-318.
46. Bradley C, Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev. 2002;18(suppl 3):S64-S69.
47. Samuel-Hodge CD, Watkins DC, Rowell KL, Hooten EG. Coping styles, well-being, and self-care behaviors among African Americans with type 2 diabetes. Diabetes Educator. 2008;34(3):501.
48. Huang ES, Brown SES, Ewigman BG, Foley EC, Meltzer DO. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care. 2007;30(10):2478-2483.
49. DeCoster VA, Cummings S. Coping with type 2 diabetes: do race and gender matter? Soc Work Health Care. 2004;40(2):37-53.
50. Samuel-Hodge CD, Headen SW, Skelly AH et al. Influences on day-to-day self-management of type 2 diabetes among African American women: spirituality, the multi-caregiver role, and other social context factors. Diabetes Care. 2000;23(7):928-933.
51. Macrodimitris SD, Endler NS. Coping, control, and adjustment in type 2 diabetes. Health Psychol. 2001;20(3):208-216.
52. Frewer L. The public and effective risk communication. Toxicol Lett. 2004;149(1-3):391-397.
53. Slovic P. Perception of risk. Science. 1987;236(4799):280-285.
54. Slovic P. Perceived risk, trust, and democracy. Risk Anal. 1993;13(6):675-682.
55. Johnson TP, Bowman PJ. Cross-cultural sources of measurement error in substance use surveys. Subst Use Misuse. 2003;38(10):1447-1490.
56. Fisher EB, Walker EA, Bostrom A, Fischhoff B, Haire-Joshu D, Johnson SB. Behavioral science research in the prevention of diabetes: status and opportunities. Diabetes Care. 2002;25(3):599-606.